The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution

BACKGROUND: Previous studies have reported up to 50% of ductal carcinoma in situ (DCIS), is HER2 positive, but the frequency of HER2-positive invasive breast cancer (IBC) is lower. The aim of this study is to characterise HER2 status in DCIS and assess its prognostic value. METHODS: HER2 status was...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Cancer
Asıl Yazarlar: Miligy, Islam M., Toss, Michael S., Gorringe, Kylie L., Lee, Andrew H. S., Ellis, Ian O., Green, Andrew R., Rakha, Emad A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738110/
https://ncbi.nlm.nih.gov/pubmed/31065110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0436-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller